跳至主要内容
临床试验/ISRCTN16142533
ISRCTN16142533已完成未知

The effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes

Alexandra Hospital0 个研究点目标入组 160 人开始时间: 2017年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
160

研究概览

简要总结

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32646482/ protocol (added 13/07/2020) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39141124/ (added 15/08/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 21/11/2017:
  • 2. Age over 18 years
  • 3. Singleton pregnancies
  • 4. Absence of pre-existing impaired glucose tolerance
  • Previous inclusion criteria:
  • 2. Age over 18 years
  • 3. Singleton pregnancies
  • 4. Diagnosis of diet-treated gestational diabetes (24 - 28 weeks of gestation)

排除标准

  • Current exclusion criteria as of 21/11/2017:
  • 1. Age under 18 years
  • 2. Multiple pregnancy
  • 3. Pre-existing diabetes mellitus
  • 4. Consumption of steroids
  • 5. Hypertensive disorders
  • 6. Hypothyroidism
  • 7. Pre-existing renal or hepatic impairment
  • 8. Beta thalassaemia carriers
  • 9. Vaginal bleeding (e.g. placental abruption)
  • 10. Special diets (e.g. lactose intolerance)
  • 11. Inadequate monitoring during pregnancy
  • Previous exclusion criteria:
  • 1. Age under 18 years
  • 2. Multiple pregnancy
  • 3. Diagnosed diabetes mellitus before 24 - 28 weeks of gestation
  • 4. Requirement of insulin therapy during the period of myo-inositol supplementation
  • 5. Chronic hypertension
  • 6. Preeclampsia, eclampsia
  • 7. Hypothyroidism
  • 8. Pre-existing renal or hepatic impairment
  • 9. Other chronic diseases (e.g. valvular heart disease)
  • 10. Vaginal bleeding (e.g. placental abruption)
  • 11. Special diets (e.g. lactose intolerance)
  • 12. Inadequate monitoring during pregnancy

研究者

相似试验